Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-000082-38Phase 4Completed
Phase 4, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Adalimumab combination arm with Placebo control arm (2 arms). Primary endpoints: Disease control by DAS28 and Structural joint outcome. Started Mar 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-000082-38.